| Product Code: ETC7650790 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel End Stage Renal Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel End Stage Renal Disease Market - Industry Life Cycle |
3.4 Israel End Stage Renal Disease Market - Porter's Five Forces |
3.5 Israel End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Israel End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Israel End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Israel End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney diseases in Israel |
4.2.2 Technological advancements in renal replacement therapy |
4.2.3 Growing awareness about the importance of early detection and treatment of end-stage renal disease |
4.3 Market Restraints |
4.3.1 High cost associated with renal replacement therapy |
4.3.2 Limited availability of organ donors for kidney transplants in Israel |
4.3.3 Stringent regulatory requirements for approval of new treatment options |
5 Israel End Stage Renal Disease Market Trends |
6 Israel End Stage Renal Disease Market, By Types |
6.1 Israel End Stage Renal Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel End Stage Renal Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel End Stage Renal Disease Market Revenues & Volume, By Calcium Succinate, 2021- 2031F |
6.1.4 Israel End Stage Renal Disease Market Revenues & Volume, By Mk-3866, 2021- 2031F |
6.1.5 Israel End Stage Renal Disease Market Revenues & Volume, By Pacritinib, 2021- 2031F |
6.1.6 Israel End Stage Renal Disease Market Revenues & Volume, By Sanguinate, 2021- 2031F |
6.1.7 Israel End Stage Renal Disease Market Revenues & Volume, By Tesidolumab, 2021- 2031F |
6.1.8 Israel End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel End Stage Renal Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Israel End Stage Renal Disease Market Revenues & Volume, By Calcimimetics, 2021- 2031F |
6.2.3 Israel End Stage Renal Disease Market Revenues & Volume, By Vitamin D, 2021- 2031F |
6.2.4 Israel End Stage Renal Disease Market Revenues & Volume, By Sterols, 2021- 2031F |
6.2.5 Israel End Stage Renal Disease Market Revenues & Volume, By Potassium Binders, 2021- 2031F |
6.2.6 Israel End Stage Renal Disease Market Revenues & Volume, By Calcium-Based, 2021- 2031F |
6.2.7 Israel End Stage Renal Disease Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.3 Israel End Stage Renal Disease Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021- 2031F |
6.3.3 Israel End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021- 2031F |
6.3.4 Israel End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021- 2031F |
6.4 Israel End Stage Renal Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Israel End Stage Renal Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel End Stage Renal Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel End Stage Renal Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Israel End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel End Stage Renal Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel End Stage Renal Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel End Stage Renal Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel End Stage Renal Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel End Stage Renal Disease Market Import-Export Trade Statistics |
7.1 Israel End Stage Renal Disease Market Export to Major Countries |
7.2 Israel End Stage Renal Disease Market Imports from Major Countries |
8 Israel End Stage Renal Disease Market Key Performance Indicators |
8.1 Average waiting time for kidney transplants in Israel |
8.2 Adoption rate of home-based dialysis treatments |
8.3 Number of patients undergoing regular screenings for early detection of renal diseases |
9 Israel End Stage Renal Disease Market - Opportunity Assessment |
9.1 Israel End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Israel End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Israel End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Israel End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel End Stage Renal Disease Market - Competitive Landscape |
10.1 Israel End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here